Clinicopathologic and Genomic Factors Impacting the Efficacy of First-Line Chemoimmunotherapy in Advanced Non–Small Cell Lung Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Thoracic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC
J Thorac Oncol 2023 Feb 10;[EPub Ahead of Print], JV Alessi, A Elkrief, B Ricciuti, X Wang, A Cortellini, VR Vaz, G Lamberti, RL Frias, D Venkatraman, CAM Fulgenzi, F Pecci, G Recondo, A Di Federico, A Barrichello, H Park, M Nishino, GM Hambelton, JV Egger, M Ladanyi, S Digumarthy, BE Johnson, DC Christiani, X Lin, JF Gainor, JJ Lin, DJ Pinato, AJ Schoenfeld, MM AwadFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.